by Dr. Corey Cutler, MD, MPH
In April's president's message, Dr. Corey Cutler, MD, MPH, reflects on the recent successful Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and...
by Blood
Researchers have identified an intensive treatment to benefit individuals with newly diagnosed multiple myeloma (NDMM) who qualify for stem cell transplantation but face unfavorable outcomes due...
by Alex Kadhim
Researchers from Memorial Sloan Kettering Cancer Center in New York have explored the potential of personalized fludarabine dosing, based on population pharmacokinetics (PK), to enhance the...
by Bone Marrow Transplantation
The combination of fludarabine and treosulfan 30 g/m2 (FluTreo) is gaining acceptance as reduced-toxicity conditioning (RTC) for older adults with acute myeloid leukemia or myelodysplastic...
by Alex Kadhim
Researchers at the University of Birmingham in the UK have explored the dynamics of inflammatory biomarkers following allogeneic hematopoietic stem cell transplantation.
by BMJ Journals
Preclinical evidence identifies human epidermal growth factor receptor 2 (HER2) as a promising candidate for chimeric antigen receptor (CAR) T-cell therapy in solid cancers but it is best to...